Answers are grounded in this paper and cite their sources.
Model based design has shown promise for synthetic biological circuits. However, many approaches remain empirical and limited in scale. Here, we develop specification models from chemical reaction network (CRN) models. These specifications encode assumptions explicitly and guarantees that must be met under those assumptions. Specifically, we show how monomial dominance relations in open CRNs induce polyhedral regime assumptions in logarithmic coordinates. These assumptions give polyhedral assume guarantee contracts that encode system behavior. Further, we show how order of magnitude dominance assumptions can be written explicitly as contract assumptions and used to derive tighter guarantees. We demonstrate two biological circuit design applications: identifying the biological mechanisms that meet the required system-level specification, and screening promoter and ribosome binding site choices to determine expression gains that satisfy a specification through contract composition and refinement. Ultimately, these results provide a path from CRN descriptions of synthetic biological parts to specification-based compositional design.
No takes yet. Share an insight, caveat, or question.
Ayush Pandey (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: